Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

pretargeting

  • You have access
    Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
    Caroline Rousseau, David M. Goldenberg, Mathilde Colombié, Jean-Charles Sébille, Philippe Meingan, Ludovic Ferrer, Pierre Baumgartner, Evelyne Cerato, Damien Masson, Mario Campone, Aurore Rauscher, Vincent Fleury, Catherine Labbe, Alain Faivre Chauvet, Jean-Sebastien Fresnel, Claire Toquet, Jacques Barbet, Robert M. Sharkey, Loic Campion and Françoise Kraeber-Bodéré
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1205-1211; DOI: https://doi.org/10.2967/jnumed.119.236000
  • Open Access
    Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
    Patrícia M.R. Pereira, Komal Mandleywala, Ashwin Ragupathi, Lukas M. Carter, Jeroen A.C.M. Goos, Yelena Y. Janjigian and Jason S. Lewis
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1569-1578; DOI: https://doi.org/10.2967/jnumed.119.225813
  • Open Access
    Tumor Imaging Using Radiolabeled Matrix Metalloproteinase–Activated Anthrax Proteins
    Mary-Ann Elvina Xavier, Shihui Liu, Thomas H. Bugge, Julia Baguña Torres, Michael Mosley, Samantha L. Hopkins, Phillip D. Allen, Georgina Berridge, Iolanda Vendrell, Roman Fischer, Veerle Kersemans, Sean Smart, Stephen H. Leppla and Bart Cornelissen
    Journal of Nuclear Medicine October 1, 2019, 60 (10) 1474-1482; DOI: https://doi.org/10.2967/jnumed.119.226423
  • You have access
    Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid–Mediated Pretargeting: In Vivo Proof of Principle
    Kristina Westerlund, Mohamed Altai, Bogdan Mitran, Mark Konijnenberg, Maryam Oroujeni, Christina Atterby, Marion de Jong, Anna Orlova, Johanna Mattsson, Patrick Micke, Amelie Eriksson Karlström and Vladimir Tolmachev
    Journal of Nuclear Medicine July 1, 2018, 59 (7) 1092-1098; DOI: https://doi.org/10.2967/jnumed.118.208348
  • You have access
    Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
    Sarah M. Cheal, Edward K. Fung, Mitesh Patel, Hong Xu, Hong-fen Guo, Pat B. Zanzonico, Sebastien Monette, K. Dane Wittrup, Nai-Kong V. Cheung and Steven M. Larson
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1735-1742; DOI: https://doi.org/10.2967/jnumed.117.193250
  • You have access
    Pretargeted Imaging and Therapy
    Mohamed Altai, Rosemery Membreno, Brendon Cook, Vladimir Tolmachev and Brian M. Zeglis
    Journal of Nuclear Medicine October 1, 2017, 58 (10) 1553-1559; DOI: https://doi.org/10.2967/jnumed.117.189944
  • You have access
    α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts
    Sandra Heskamp, Reinier Hernandez, Janneke D.M. Molkenboer-Kuenen, Markus Essler, Frank Bruchertseifer, Alfred Morgenstern, Erik J. Steenbergen, Weibo Cai, Christof Seidl, William J. McBride, David M. Goldenberg and Otto C. Boerman
    Journal of Nuclear Medicine June 1, 2017, 58 (6) 926-933; DOI: https://doi.org/10.2967/jnumed.116.187021
  • You have access
    Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial
    Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Aurore Rauscher, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1505-1511; DOI: https://doi.org/10.2967/jnumed.116.172221
  • You have access
    Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses
    Jacob L. Houghton, Brian M. Zeglis, Dalya Abdel-Atti, Ritsuko Sawada, Wolfgang W. Scholz and Jason S. Lewis
    Journal of Nuclear Medicine March 1, 2016, 57 (3) 453-459; DOI: https://doi.org/10.2967/jnumed.115.163824
  • You have access
    Diabody Pretargeting with Click Chemistry In Vivo
    Sander M.J. van Duijnhoven, Raffaella Rossin, Sandra M. van den Bosch, Michael P. Wheatcroft, Peter J. Hudson and Marc S. Robillard
    Journal of Nuclear Medicine September 1, 2015, 56 (9) 1422-1428; DOI: https://doi.org/10.2967/jnumed.115.159145

Pages

  • Next
  • 1
  • 2
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire